Category Archives: Clinical Cardiology

Promising results were observed in a small, prospective study published in JAMA, in which patients with chemotherapy-induced cardiomyopathy (CHIC) were treated with cardiac resynchronization therapy (CRT).1 Certain cytotoxic agents, especially anthracyclines, as well as other anticancer treatments such as some monoclonal antibodies and tyrosine kinase inhibitors, are associated with an increased risk of cardiomyopathy. Termed CHIC, this progressive condition is believed to be due to drug-related myocyte death, resulting in ventricular remodeling, and ultimately leading to heart failure Continue reading →

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global small animal imaging market since 2019 and the market is poised to grow by USD 959.08 million during 2020-2024, progressing at a CAGR of more than 9% during the forecast period. Continue reading →

KGH and NGH have announced plans to merge their managers and appoint a top boss to oversee both hospitals. Continue reading →

Dublin, Jan. 10, 2020 (GLOBE NEWSWIRE) -- The "Global In-Vitro Diagnostics (IVD) Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The major factors contributing to the growth of the market include a significant rise in the prevalence of chronic and infectious diseases, growing technological advances in IVD testing tools and the rising adoption of non-invasive diagnostic tests. Continue reading →

New research bolsters a connection between the risk for cancer before and after peripartum cardiomyopathy (PPCM) and identifies genetic variants underlying PPCM and a variety of cancers. "This study is the first to describe a markedly increased risk for malignancies both before and after the diagnosis of PPCM," TobiasJ Continue reading →

Syed Hassan Abbas Kazmi, Sudarshana Datta, Gerald Chi, Tarek Nafee, Megan Yee, Akshun Kalia, Sadaf Sharfaei, Fahimehalsadat Shojaei, Sabawoon Mirwais, C Michael Gibson Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Correspondence: C Michael Gibson PERFUSE Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 930 Commonwealth Ave. #3, Boston, MA 02215, USA Tel +1-617-975-9950 Email mgibson@bidmc.harvard.edu Abstract: Total ischemic time, which specifies the time from the onset of chest pain to initiation of reperfusion during percutaneous coronary intervention, consists of two intervals: symptom to door time and door to balloon time. Continue reading →

Animal care specialists at the San Diego Zoo Safari Park were concerned when they noticed cloudiness in the left eye of Leslie, a 3-year-old female western lowland gorilla. Continue reading →

Hypertrophic cardiomyopathy in black vs white patients may be associated with a greater burden of functional heart failure and reduced access to care and genetic testing, according to a study published in JAMA Cardiology. Continue reading →

Cholesterol-lowering statin medications have been at the forefront of managing cardiovascular disease for several decades now. Why? Its because a large body of research supports their benefits in reducing the risk of heart attack and stroke. Continue reading →

SHEBOYGAN, Wis., Jan. Continue reading →